Adalimumab, a fully human immunoglobulin (Ig) G1 neutralizing monoclonal antibody specific to tumor necrosis factor-α (TNF-α) is used in the treatment of many chronic inflammatory diseases, especially RA [11-12]. Here, TNF is linked to rheumatoid arthritis.